Smith Anglin Financial’s Cognition Therapeutics CGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.72K Hold
2025
Q1
$5.05K Hold
2024
Q4
$8.42K Hold
2024
Q3
$5.62K Hold
2024
Q2
$19.9K Hold
2024
Q1
$21.8K Hold
2023
Q4
$22.2K Buy